Analysis Cnbx Pharmac.ew: Investor Focus Shifts to Clinical Trial Launch and Funding
The biopharmaceutical firm Cnbx Pharmac.ew finds itself at a critical juncture. The company’s future valuation is increasingly tied to two imminent catalysts: the initiation of human trials for its lead...